November 11th 2024
AHA 2024. Study authors reported a 74% lower risk of death and an 84% lower risk of MI among participants taking either a GLP-1RA or an SGLT2i.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Cases and Conversations: Evidence-Based Approaches to Management of CKD in Your Patients With T2DM
View More
Raising Our Game in the Management of Hyperlipidemia: New Targets, New Tactics
View More
Incomplete LV Rupture Secondary to MI: A Case of Intramyocardial Dissection
November 21st 2013Myocardial rupture is the most feared and often lethal complication of acute MI. It was a potential diagnosis for this patient who presented with sinus tachycardia, ST-segment elevation from V1 to V4, II, III, and aVF with associated Q waves. Follow the workup and outcome here.
ACC/AHA Prevention Guidelines: Highlights of the Top 3 Changes
November 20th 2013Many years in the making, the revised guidelines on preventing elevated blood cholesterol depart in significant ways from the last version of the NHLBI's ATP III. Here, the top 3 differences primary care physicians will want to know more about.
Good Culinary News for Statin-Intolerant Patients
October 17th 2013The real impact of nutritious menu changes at fast food chains like McDonalds remains to be seen, but these-along with modifying the dosage schedules of patients who appear to be statin-intolerant-may prove to have long-term salubrious effects.
Low Testosterone Syndrome Rx: Still Waiting for Godot
September 27th 2013A little bit of knowledge can be a dangerous thing, and I am proof. There is a lot more to the saga and much of the information is essential to decision making in primary care practice on whether or not testosterone replacement is indicated.